From the Professor..., page-126

That's strange Mason..

If your data is so much more encouraging, and the market for these FTO inhibitors and cardio synergy are so blue sky by comparison to the small solid tumor market IMU are targeting,
Why do you guys need the CEO over there hand-holding shareholders every 3 minutes on the threads?

Surely BP would be tripping over themselves to hand you suitcases of cash, no?


Strange also how IMU holders don't need to go over to your threads and downramp your one tick pony?
Serial Pest, back on ignore where you belong.